HNC-280

N/A

Report date: 2025/03/18 14:44:57

Base Information

Drug NameHNC-280
Drug Alias NameHNC-280HNC280HNC-280（2.1类改良型）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHBV DNA Polymerase inhibitors
TargetsHBV DNA Polymerase
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou Henovcom Bioscience Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Henovcom Bioscience Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A